查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702242

2025 年至 2033 年α发射体市场规模、份额、趋势及预测（按放射性核种类型、医疗应用、最终用户和地区划分）

Alpha Emitter Market Size, Share, Trends and Forecast by Type of Radionuclide, Medical Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球 α 发射体市场规模价值 18.3448 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 120.402 亿美元，2025 年至 2033 年的复合年增长率为 23.25%。北美目前占据市场主导地位，到 2024 年其市占率将超过 43.7%。对标靶癌症治疗的关注度不断提高，以及新核子医学产品获批数量的不断增加等因素，正在增强 α 发射体的市场份额。

阿尔法发射体是由放射源发射的物质，在释放阿尔法粒子后会衰变。它们实现适当的生物分布和相关的剂量分布，以实现有效的治疗，而不会引起不可接受的急性或长期副作用。由于具有极高的细胞杀伤率，在医疗过程中使用时，α粒子对肿瘤细胞的破坏性比β粒子更大。因此，它们对邻近正常组织的损害较小。镭、铅和铋是治疗过程中使用的一些放射性核种。阿尔法粒子的短射程和高线性能量传输 (LET) 使其在医学研究中具有极大的吸引力，尤其是作为一种可行的癌症治疗方法。许多类型的癌症可以用α发射体治疗，包括卵巢癌、胰臟癌、淋巴瘤和黑色素瘤。

α发射体市场趋势：

该市场主要受到癌症治疗领域广泛而高端的研究与开发 (R&D) 活动的推动。这可以归因于人们对靶向阿尔法发射体的细胞杀伤能力的认识不断提高。同时，各类癌症在人群中的发生率不断上升，为市场提供了推动力。此外，老年人口的不断增加，更容易患上多种心臟病和癌症，这为市场带来了积极的前景。此外，医疗机构越来越多地采用标靶抗癌疗法或阿尔法疗法 (TAT) 来治疗癌症，这对市场产生了积极影响。技术的不断进步和越来越多的新型核医学产品获批进一步推动了市场的发展。其他影响市场发展的因素包括快速城市化、医疗基础设施的不断改善、医疗支出的增加以及个人可支配收入水准的提高。

本报告回答的关键问题

  • 阿尔法发射体市场有多大？阿尔法发射体市场的未来前景如何？
  • 推动阿尔法发射体市场发展的关键因素有哪些？
  • 哪个地区占据最大的阿尔法发射体市场份额？
  • 全球阿尔法发射体市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球α发射体市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依放射性核种类型

  • 砈
  • 镭
  • 锟
  • 带领
  • 铋
  • 其他的

第七章：市场区隔：依医疗应用

  • 摄护腺癌
  • 骨转移
  • 卵巢癌
  • 胰腺癌
  • 内分泌肿瘤
  • 其他的

第八章：市场区隔：按最终用户

  • 医院
  • 医学研究机构
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Actinium Pharmaceuticals Inc.
    • Alpha Tau Medical Ltd.
    • Bayer AG
    • Fusion Pharmaceuticals
    • IBA RadioPharma Solutions
    • RadioMedix Inc.
Product Code: SR112025A6398

The global alpha emitter market size was valued at USD 1,834.48 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 12,040.20 Million by 2033, exhibiting a CAGR of 23.25% from 2025-2033. North America currently dominates the market, holding a market share of over 43.7% in 2024. Factors such as the increasing focus on targeted cancer treatments, along with the rising number of new nuclear-medicine-based product approvals, are bolstering the alpha emitter market share.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

Breakup by Type of Radionuclide:

  • Astatine
  • Radium
  • Actinium
  • Lead
  • Bismuth
  • Others

Breakup by Medical Application:

  • Prostate Cancer
  • Bone Metastasis
  • Ovarian Cancer
  • Pancreatic Cancer
  • Endocrine Tumors
  • Others

Breakup by End User:

  • Hospitals
  • Medical Research Institutions
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Key Questions Answered in This Report

  • 1.How big is the alpha emitter market?
  • 2.What is the future outlook of alpha emitter market?
  • 3.What are the key factors driving the alpha emitter market?
  • 4.Which region accounts for the largest alpha emitter market share?
  • 5.Which are the leading companies in the global alpha emitter market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alpha Emitter Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type of Radionuclide

  • 6.1 Astatine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radium
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Actinium
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lead
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Bismuth
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Medical Application

  • 7.1 Prostate Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Metastasis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ovarian Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Endocrine Tumors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Actinium Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Alpha Tau Medical Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Pharmaceuticals
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 RadioMedix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

List of Figures

  • Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
  • Figure 2: Global: Alpha Emitter Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2024
  • Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2024
  • Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
  • Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
  • Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million USD), 2025-2033
  • Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million USD), 2025-2033
  • Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Alpha Emitter Market: Competitive Structure
  • Table 7: Global: Alpha Emitter Market: Key Players